Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Web Exclusives
Comprehensive Treatment Improves Outcomes for Veterans With Early-Stage Lung Cancer
Web Exclusives
— November 7, 2024
Read Article
Online First
Artificial Intelligence Holds Promise for Lung Cancer Detection
Lung Cancer
Web Exclusives
— September 25, 2024
Artificial intelligence holds promise for detecting lung cancer if research presented at the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer is any indicator.
Read Article
PM2.5 Exposure May Play Role in Lung Cancer Development
Lung Cancer
Web Exclusives
— September 25, 2024
Patients diagnosed with stage IV lung cancer displayed higher proportions of EGFR mutations compared to those without.
Read Article
Pearls for Boosting Clinical Trial Participation in Underrepresented Populations
By
Colleen Hall
Clinical Trials
Web Exclusives
— August 21, 2024
Encouraging diverse populations to participate in clinical trials is key as new FDA guidance released.
Read Article
Incidence of Colorectal Cancer Rising in Young Adults
Cancer Awareness
,
Colorectal Cancer
Web Exclusives
— July 1, 2024
Colorectal cancer (CRC) is the second most common cause of cancer-related death in the United States and is the leading cause of death in men aged <50 years.
Read Article
FDA Granted Second Approval for Epkinly to Treat Patients With Relapsed or Refractory Follicular Lymphoma
FDA Approvals, News & Updates
,
Lymphoma
,
Bispecific Antibodies
Web Exclusives
— June 28, 2024
On
June 26, 2024
, the FDA approved epcoritamab-bysp (Epkinly; Abbvie and Genmab) as the first and only T-cell engaging bispecific antibody administered subcutaneously for the treatment of adults with relapsed or refractory follicular lymphoma (FL) after ≥2 lines of prior therapy.
Read Article
Pembrolizumab With Chemotherapy for Some Endometrial Carcinomas Gets Green Light
FDA Approvals, News & Updates
Web Exclusives
— June 18, 2024
FDA officials approved pembrolizumab (Keytruda, Merck) with carboplatin and paclitaxel, followed by single-agent pembrolizumab, for adult patients with primary advanced or recurrent endometrial carcinoma efficacy of this treatment was evaluated in KEYNOTE-868/NRG-GY018.
Read Article
Addressing Cancer Health Disparities: The No One Left Alone Initiative
By
Rohan Nathwani
;
Arva Patel
;
Warner Kornberg
;
Asutosh Gor, MD
;
Sashi Naidu, MD
;
Viral Rabara, MD
;
Niyati Nathwani, MD
;
Kashyap Patel, MD
Health Disparities
Web Exclusives
— May 14, 2024
Despite ranking among the top 6 wealthiest economies in the world per capita, the United States still has sizable health disparities among its citizens, which are rooted in social, economic, and environmental factors. Place of birth is more strongly associated with life expectancy than race or genetics.
Read Article
Navigating the Complex Landscape of Oral Cancer Medication
Oral Oncolytics
Web Exclusives
— April 15, 2024
Recognizing the complexities of treatment with oral medications is an important step toward successful outcomes.
Read Article
Tornado Sweeps Through Pfizer’s Storage and Manufacturing Facility
FDA Approvals, News & Updates
Web Exclusives
— August 7, 2023
On July 19, 2023, an EF3 tornado touched down in Rocky Mount, NC, badly damaging a Pfizer drug manufacturing facility that is responsible for producing nearly 25% of Pfizer’s sterile injectable medicines used in US hospitals.
Read Article
Page 3 of 13
1
2
3
4
5
6
Top Trending Articles
1.
ACCC Federal Policy Update Highlights Key Risks and Opportunities for Oncology Practices in 2026
Meg Barbor, MPH
2.
The Evolving Landscape of Lung Cancer Care
Meg Barbor, MPH
3.
AUGTYRO (Repotrectinib) for the Treatment of ROS1-Positive Non-Small Cell Lung Cancer
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma